BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 5-Aminoimidazole-4-Carboxamide Riboside (AICAR) and Its Derivatives Using Inosine as Starting Material. 2015

Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Dipartimento di Farmacia, Università degli Studi di Napoli 'Federico II', Napoli, Italy.

This unit contains four basic protocols describing the synthesis of 5-aminoimidazole-4-carboxamide riboside (AICAR), 5-aminoimidazole-4-carboxamide riboside (ZPM), their 4-N functionalized derivatives, and two sugar-modified analogs of AICAR. The first and second basic protocols reveal the importance of solid-phase synthesis to obtain novel AICAR and ZMP imidazole-modified analogs in a short time, whereas the third and fourth basic protocols allow for the rapid preparation of 5'-F-AICAR and D-ribityl AICA.

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D000620 Aminoimidazole Carboxamide An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. Ba 2756,Carboxamide, Aminoimidazole
D012265 Ribonucleotides Nucleotides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed) Ribonucleoside Phosphates,Ribonucleotide,Phosphates, Ribonucleoside

Related Publications

Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes.
June 2018, Acta diabetologica,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
5-Aminoimidazole-4-carboxamide riboside (AICAr) administration reduces cerebral ischemic damage in the Mongolian gerbil.
July 1990, Brain research bulletin,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.
January 2005, The Biochemical journal,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR). Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates.
March 2004, The Journal of biological chemistry,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
January 2003, Neuroscience,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
1-Glycosyl derivatives of 5-aminoimidazole-4-carboxamide.
December 1972, Journal of medicinal chemistry,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Regulation of phosphatidylcholine and phosphatidylethanolamine synthesis in rat hepatocytes by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
February 2002, The Biochemical journal,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Estradiol Regulates Dorsal Vagal Complex Signal Transduction Pathway Transcriptional Reactivity to the AMPK Activator 5-Aminoimidazole-4-Carboxamide-Riboside (AICAR).
August 2015, Journal of molecular neuroscience : MN,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
September 2006, Molecular cancer therapeutics,
Stefano D'Errico, and Giorgia Oliviero, and Nicola Borbone, and Vincenzo Piccialli, and Gennaro Piccialli
Antitumor activity of 4 (or 5)-aminoimidazole-5 (or 4)-carboxamide derivatives.
August 1965, Gan,
Copied contents to your clipboard!